EFTA00489771.pdf
dataset_9 pdf 101.7 KB • Feb 3, 2026 • 3 pages
From:
To: Rich Kahn
Subject: Re:
Date: Thu, 17 Jan 2019 22:20:51 +0000
got it! thanks
On Jan 17, 2019, at 5:20 PM, Richard Kahn wrote:
i asked JEE and he said to ignore so no need to follow up with jee..
thanks
Richard Kahn
MO=
tel
fax
cell
On Jan 17, 2019, at 4:04 PM, wrote:
Thx
Sent from my iPhone
On Jan 17, 2019, at 3:50 PM, Richard Kahn wrote:
i will mention to jee when we speak next
thanks
Richard Kahn
tel
fax
cell
EFTA00489771
On Jan 17, 2019, at 12:19 PM, > wrote:
Christina requested I forward you the below `catch up' email.
BioHebe
cell:
CIllail:
\IA vi.biohthe.com
<1506365439123b1ob.jpg>
Forwarded Message
Fro >
To: < >:
Sent: Wednesday, January 16, 2019. 11:22:06 PM EST
Subject: Catching Up
Dear Jeffrey
I hope you've been well. I wanted to update you on what I've been up to for the last two years. I was also
hoping to talk with you to see if I might use the foundation's Lexington office conference room from
time to time for my work and what I could provide in exchange for that. I am cc'ing Rich because I'm not
sure if you still use this email?
Since working for your foundation, I continued to publish as a journalist writing mostly about genetic
vectors (Newsweek, Teclzonomy etc). I then set up an LLC that provides business development for labs
that have reversed age-driven or degenerative diseases. Most of the therapies are genetic vectors, and
have to show remarkable results at the mouse level and beyond. Regenerative medicine is a rapidly
evolving field, and one that forces the medical industry to shift their focus from addressing symptoms of
disease to fundamental evolutionary shortfalls.
So far, I placed a genetic vector at the National Institute of Medicine in France (that reversed glaucoma
in mice using the neuroglobin gene) under formal licence review with a publicly traded pharma group
here in the US. And I am collaborating with a lab at the University of Pittsburgh that has reversed
cirrhosis/ end stage liver disease in rats using the master transcription gene in hepatocytes. The concept
of the latter gene vector is really intriguing in that a master transcription gene completely restored liver
function by rebalancing genetic expression and thus proteostasis.
While I don't really need an office at this point, I do need access to a conference room from time to time
and it would be hugely helpful if I could access the foundation's. If there was some work that I could do
for the foundation in exchange, I would be delighted to do that.
EFTA00489772
It would be wonderful to catch up with you as well.
all the best,
BioHebe I.LC:
cell:
email: -
www.Mohehe.com
<1506365439123b1ob.jpg>
<1506365439123blobjpe<1506365439123blobjpg>
EFTA00489773
Entities
0 total entities mentioned
No entities found in this document
Document Metadata
- Document ID
- ba34c023-2734-4907-8526-afcddd93218a
- Storage Key
- dataset_9/EFTA00489771.pdf
- Content Hash
- bc830393bc2118e8180873e5936ce412
- Created
- Feb 3, 2026